ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Nature Genetics2013Vol. 45(12), pp. 1439–1445
Citations Over TimeTop 1% of 2013 papers
Weiyi Toy, Yang Shen, Helen Won, Bradley Green, Rita A. Sakr, Marie Will, Zhiqiang Li, Kinisha Gala, Sean W. Fanning, Tari A. King, Clifford A. Hudis, David Chen, Tetiana Taran, Gabriel N. Hortobágyi, Geoffrey L. Greene, Michael F. Berger, José Baselga, Sarat Chandarlapaty
Related Papers
- → Complete elimination of estrogen receptor α by PROTAC estrogen receptor α degrader ERD-148 in breast cancer cells(2023)10 cited
- → Tamoxifen and Fulvestrant Hybrids Showed Potency as Selective Estrogen Receptor Down-Regulators(2016)2 cited
- → Fulvestrant-Mediated Inhibition of Estrogen Receptor Signaling Slows Lung Cancer Progression(2014)22 cited
- → Estrogen receptor-alpha-interacting cytokeratins potentiate the antiestrogenic activity of fulvestrant(2010)12 cited
- → Estrogen-dependent regulation of Eg5 in breast cancer cells(2007)9 cited